2021-08-02-世界卫生组织-Weekly_epidemiological_update_on_COVID-19_-_3_August_2021_14页_2mb

报告摘要

Summary of COVID-19 Weekly Epidemiological Update (Edition 51, August 3, 2021)

New COVID-19 cases surpassed 4 million in the past week, driven largely by increases in the Eastern Mediterranean and Western Pacific Regions.
Weekly deaths decreased by 8% to over 64,000 globally, with sharp increases in deaths reported in the Eastern Mediterranean and Western Pacific.
Cumulative cases reached nearly 197 million, deaths 4.2 million.
High case incidence per 100,000 population continued in the Americas and Europe.
Top countries by new cases: United States, India, Indonesia, Brazil, Iran.
Variants reported: Alpha in 182 countries, Beta in 132 countries, Gamma in 81 countries, Delta in 135 countries.

WHO assesses variants for impacts on transmission, disease severity, and response measures.
The number of countries reporting variants increased, with variants detected in travelers and local cases.
Updated surveillance and research recommended based on variant risks, including risk mitigation for international travel.

Americas Region: Saw high case counts in the United States and Brazil, with a decrease in deaths after previous inaccuracies; regions reported around 1.2 million cases, but deaths dropped.
African Region: Recorded over 182,000 new cases with a modest decrease in deaths; high cases in countries like South Africa.
Eastern Mediterranean Region: Experienced a large increase in cases (37% from previous week), driven by Iran and others; stable deaths.
European Region: Reported declining cases (9% decrease) but stable deaths; cases high in countries like France.
South-East Asia Region: Cases increased by 9%, deaths remained similar; main drivers like Japan and Malaysia.
Western Pacific Region: Cases surged by 33%, deaths increased sharply by 48%-related countries.

WHO Director-General highlighted the launch of the RADAR initiative for $7.7 billion to combat Delta, aiming for global vaccination targets beyond September.
Recommendations include enhanced guidance on gatherings, ChAdOx1 vaccine use, and joint efforts to boost vaccine production and access.

展开完整摘要